Justin M Drake

20052021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 16 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Phosphorylation Chemical Compounds
Phosphopeptides Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2021

phosphotransferases (kinases)
phenotype
Prostatic Neoplasms
Phosphotransferases

Research Output 2005 2019

3 Citations (Scopus)

DNA-dependent protein kinase drives prostate cancer progression through transcriptional regulation of the Wnt signaling pathway

Kothari, V., Goodwin, J. F., Zhao, S. G., Drake, J. M., Yin, Y., Chang, S. L., Evans, J. R., Wilder-Romans, K., Gabbara, K., Dylgjeri, E., Chou, J., Sun, G., Tomlins, S. A., Mehra, R., Hege, K., Filvaroff, E. H., Schaeffer, E. M., Karnes, R. J., Quigley, D. A., Rathkopf, D. E. & 9 others, He, H. H., Speers, C., Spratt, D. E., Gilbert, L. A., Ashworth, A., Chinnaiyan, A. M., Raj, G. V., Knudsen, K. E. & Feng, F. Y., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5608-5622 15 p.

Research output: Contribution to journalArticle

DNA-Activated Protein Kinase
Wnt Signaling Pathway
Prostatic Neoplasms
Phosphotransferases
Wnt Proteins
3 Citations (Scopus)

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nickols, N. G., Nazarian, R., Zhao, S. G., Tan, V., Uzunangelov, V., Xia, Z., Baertsch, R., Neeman, E., Gao, A. C., Thomas, G. V., Howard, L., De Hoedt, A. M., Stuart, J., Goldstein, T., Chi, K., Gleave, M. E., Graff, J. N., Beer, T. M., Drake, J. M., Evans, C. P. & 11 others, Aggarwal, R., Foye, A., Feng, F. Y., Small, E. J., Aronson, W. J., Freedland, S. J., Witte, O. N., Huang, J., Alumkal, J. J., Reiter, R. E. & Rettig, M. B., Dec 2019, In : Prostate Cancer and Prostatic Diseases.

Research output: Contribution to journalArticle

Castration
Mitogen-Activated Protein Kinase Kinases
Prostatic Neoplasms
Therapeutics
Phosphotransferases

Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells

Brian, B. F., Jolicoeur, A. S., Guerrero, C. R., Nunez, M. G., Sychev, Z. E., Hegre, S. A., Sætrom, P., Habib, N., Drake, J. M., Schwertfeger, K. L. & Freedman, T. S., Jul 2019, In : eLife. 8, e46043.

Research output: Contribution to journalArticle

Open Access
Phosphorylation
src-Family Kinases
Macrophages
Myeloid Cells
Tuning
4 Citations (Scopus)

Impact of phosphoproteomics in the era of precision medicine for prostate cancer

Ramroop, J. R., Stein, M. N. & Drake, J. M., Feb 16 2018, In : Frontiers in Oncology. 8, FEB, 28.

Research output: Contribution to journalReview article

Open Access
Precision Medicine
Prostatic Neoplasms
Castration
Phosphopeptides
Mass Spectrometry
8 Citations (Scopus)

MAPK Reliance via acquired CDK4/6 inhibitor resistance in cancer

De Leeuw, R., McNair, C., Schiewer, M. J., Neupane, N. P., Brand, L. J., Augello, M. A., Li, Z., Cheng, L. C., Yoshida, A., Courtney, S. M., Starr Hazard, E., Hardiman, G., Hussain, M. H., Alan Diehl, J., Drake, J. M., Kevin Kelly, W. & Knudsen, K. E., Sep 1 2018, In : Clinical Cancer Research. 24, 17, p. 4201-4214 14 p.

Research output: Contribution to journalArticle

Open Access
Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Neoplasms
Mitogen-Activated Protein Kinase Kinases
Cell Cycle Checkpoints